A Phase I Safety Study of Phenylephrine Applied Topically to the Oral Mucosa in Cancer Patients Receiving Radiation to Sub-mandibular Lymph Nodes
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Safety: the presence or absence of mucosal or systemic toxicity related the the topical application of phenylephrine.
James F Cleary, MBBS
University of Wisconsin, Madison
United States: Food and Drug Administration
|University of Wisconsin Carbone Cancer Center||Madison, Wisconsin 53792-5669|